Item | Value | Budoff et al. [15] | Baumgart et al. [16] | Seese et al. [17] | Yao et al. [18] | Chen et al. [19] | Bielak et al. [20] | Hosoi et al. [21] | Budoff et al. [22] | Almeda et al. [23] | Knez et al. [24] |
---|---|---|---|---|---|---|---|---|---|---|---|
Patient recruitment | NR: Not reported | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | NR | 1 |
 | 1: Undergoing CAG for clinical indications |  |  |  |  |  |  |  |  |  |  |
Exclusion criteria | NR: Not reported | NR | 1 | NR | NR | 1 | 1 | NR | 1 | NR | NR |
 | 1: History of CAD/revascularization |  |  |  |  |  |  |  |  |  |  |
Outcome defined | 1: No | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
 | 2: Yes |  |  |  |  |  |  |  |  |  |  |
EBCT categories | 1: Quartiles or pre-selected cut-offs | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
 | 2: Age – sex adjusted |  |  |  |  |  |  |  |  |  |  |
Outcome measurement blinded to EBCT score | 1: No | NR | 2 | NR | NR | 2 | NR | 2 | 2 | NR | 2 |
 | 2: Yes |  |  |  |  |  |  |  |  |  |  |
Demographic characteristics | NR: Not reported | 1 | 1 | 1 | NR | 1 | 1 | 1 | 1 | 1 | 1 |
 | 1: Reported |  |  |  |  |  |  |  |  |  |  |
Risk factors | NR : Not reported | NR | NR | NR | NR | 1 | 1 | 1 | NR | 1 | 1 |
 | 1: Reported (see Table 3) |  |  |  |  |  |  |  |  |  |  |
Adjusted results available | 1: Yes but cannot be used in meta-analysis | 1 | NR | NR | NR | 2 | 3 | 1 | 2 | 2 | NR |
 | 2: Yes at single cut-off and can be used in meta-analysis. |  |  |  |  |  |  |  |  |  |  |
 | 3: Yes at multiple cut-offs and can be used in meta-analysis |  |  |  |  |  |  |  |  |  |  |
Total | Maximum: 13 | 6 | 8 | 5 | 4 | 11 | 10 | 9 | 10 | 7 | 8 |